New drug update: 2008.
Only 16 new therapeutic agents were marketed in the United States in 2008, the lowest number in many years. Four new drugs have been selected for consideration in this review. The uses and most important properties of each agent are considered, and a rating for each new drug is provided using the New Drug Comparison Rating (NDCR) system developed by the author.
Hussar
Daniel A
DA
Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, Philadelphia, Pennsylvania, USA.
D000818:Animals; D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001578:Benzopyrans / Q000494:pharmacology / Q000627:therapeutic use*; D003511:Cyclohexanols / Q000627:therapeutic use*; D000069468:Desvenlafaxine Succinate; D004983:Ethanolamines / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D009271:Naltrexone / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D000068577:Nebivolol; D011282:Pregnenediones / Q000494:pharmacology / Q000627:therapeutic use*; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology / Q000627:therapeutic use
D018926:Anti-Allergic Agents; D000928:Antidepressive Agents; D000959:Antihypertensive Agents; D001578:Benzopyrans; D003511:Cyclohexanols; D004983:Ethanolamines; D009292:Narcotic Antagonists; D011282:Pregnenediones; D000644:Quaternary Ammonium Compounds; D000068577:Nebivolol; C032257:methylnaltrexone; D009271:Naltrexone; C120481:ciclesonide; D000069468:Desvenlafaxine Succinate